Trial intelligence / Profile preview

Autologous Blood vs Corticosteroid vs Combination for Lateral Epicondylitis

NCT06236178Completed

Sponsor
Istanbul Education Research Hospital
Start
Jan 2023
Primary completion
Oct 2023
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised trial of autologous blood and methylprednisolone in Lateral Epicondylitis (LET) (3 arms), sponsored by Istanbul Education Research Hospital. Primary endpoint: Patient-Rated Tennis Elbow Evaluation at Day 90. Started Jan 2023; status: completed.

02

Drugs

autologous bloodmethylprednisolone
03

Conditions

Lateral Epicondylitis (LET)

Beyond the preview

Go deeper on NCT06236178.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06236178.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call